Rare diseases
Investigational molecules
Locations
Rk Gebouw, Kloosterstraat 9, 5349 AB, The Netherlands
Citryll B.V. focuses on inflammatory mediated immune diseases with studies aimed at understanding how its investigational program behaves in immune-driven conditions. This area reflects interest in immunology and the treatment of chronic inflammatory disorders.
The sponsor’s research activity in this area includes work spanning multiple countries and collaborating sites, supporting clinical evaluation in broad immune-inflammatory settings.
Citryll B.V. runs clinical trials in conditions such as Rheumatoid arthritis, Autoimmune disorder, Hidradenitis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Study of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis
BelgiumStudy Using PET Imaging to See How [89Zr]Zr-DFO-CIT-013 Spreads in Patients with Inflammatory Mediated Immune Diseases
The NetherlandsEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
